
Eli Lilly’s Weight-Loss Drug Sales Disappoint! Shocked Investors React
Eli Lilly has recently made headlines after announcing disappointing sales forecasts for their weight-loss medicine Zepbound and diabetes treatment Mounjaro. The company’s predictions for the fourth quarter fell short of Wall Street expectations, causing their stock to plummet more than 8%. Despite